Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title	Author(s)
	Dec-1994	Rapid detection of Rh(D)- or K-positive fetal red cells in chorion villus samples by a flow cytometric technique	Forsyth, Cecily J ; Nelson, M.; Popp, H.; Gibson, J.
	1994	Development of a flow cytometric test for the detection of D-positive fetal cells after fetomaternal hemorrhage and a survey of the prevalence in D-negative women	Forsyth, Cecily J ; Nelson, M.; Popp, H.; Horky, K.; Gibson, J.
	Nov-1992	Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron	Forsyth, Cecily J ; Coates, A.S.; Childs, A.; Cox, K.; Joshua, D.E.; McNeil, E.; Grygiel, J.J.
	Aug-2018	Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features	Forsyth, Cecily J ; Godfrey, A.L.; Campbell, P.J.; MacLean, C.; Buck, G.; Cook, J.; Temple, J.; Wilkins, B.S.; Wheatley, K.; Nangalia, J.; Grinfeld, J.; McMullin, M.F.; Kiladjian, J.J.; Green, A.R.; Harrison, C.N.
	Dec-2018	The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complications	Forsyth, Cecily J ; Melville, K.; Tiley, Campbell
	Apr-2018	Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia	Forsyth, Cecily J ; Crassini, K.R.; Zhang, E.; Balendran, S.; Freeman, J.A.; Best, O.G.; Mackinlay, N.J.; Han, P.; Stevenson, W.S.; Mulligan, S.P.
	Jan-2018	Delayed-onset heparin-induced thrombocytopenia complicated by arterial and venous thromboses	Forsyth, Cecily J ; Harrison; Balendran, S.; Harrison, A.; Morel-Kopp, M. C.; Ward, C.
	May-2017	Raccoon eyes in systemic light chain amyloidosis	Forsyth, Cecily J ; Tiley, Campbell
	May-2017	The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia	Forsyth, Cecily J ; Fox, L.; Cummins, K.D.; Costello, B.; Yeung, D.; Cleary, R.; Tatarczuch, M.; Burbury, K.; Motorna, O.; Shortt, J.; Fleming, S.; McQuillan, A.; Schwarer, A.; Harrup, R.; Holmes, A.; Ratnasingam, S.; Chan, K.L.; Hsu, W.H.; Ashraf, A.; Putt, F.; Grigg, A.
	Mar-2017	A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosis	Forsyth, Cecily J ; Ho, P.J.; Bajel, A.; Burbury, K.; Dunlop, L.; Durrant, S.; Perkins, A.C.; Ross, D.M.
	May-2017	Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study	Forsyth, Cecily J ; Quach, H.; Fernyhough, L.; Henderson, R.; Corbett, G.; Baker, B.; Browett, P.; Blacklock, H.; Underhill, C.; Cannell, P.; Trotman, J.; Neylon, A.; Harrison, S.; Link, E.; Swern, A.; Cowan, L.; Dimopoulos, M.A.; Miles Prince, H.
	Apr-2016	Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms	Forsyth, Cecily J ; Malherbe, J.A.; Fuller, K.A.; Mirzai, B.; Kavanagh, S.; So, C.C.; Ip, H.W.; Guo, B.B.; Howman, R.; Erber, W.N.
	Feb-2015	The oral iron chelator deferasirox inhibits NF-kappaB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia	Forsyth, Cecily J ; Banerjee, A.; Mifsud, N. A.; Bird, R.; Szer, J.; Tam, C.; Kellner, S.; Grigg, A.; Motum, P.; Bentley, M.; Opat, S.; Grigoriadis, G.
	Jul-2014	Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy	Forsyth, Cecily J ; Paidas, M.J.; Quere, I.; Rodger, M.
	May-2014	Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea	Forsyth, Cecily J ; Verner, E.; Grigg, A.
	Jan-2013	Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia	Forsyth, Cecily J ; Freeman, J.A.; Crassini, K.R.; Best, O.G.; Mackinlay, N.J.; Han, P.; Stevenson, W.S.; Mulligan, S.P.
	Aug-2016	Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort	Forsyth, Cecily J ; Campbell, P.J.; MacLean, C.; Beer, P.A.; Buck, G.; Wheatley, K.; Kiladjian, J.J.; Harrison, C.N.; Green, A.R.
	Jul-2012	The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease	Forsyth, Cecily J ; Best, O.G.; Che, Y; Singh, N.; Christopherson, R.I.; Mulligan, S.P.
	Feb-2012	Distinguishing types 1 and 2M von Willebrand disease	Forsyth, Cecily J ; Favaloro, E.J.; Koutts, J.
	Nov-2018	Recommendations for the use of pegylated interferon-alpha in the treatment of classical myeloproliferative neoplasms	Forsyth, Cecily J ; Chan, Wai-Hoong ; Grigg, A.; Cook, N.C.; Lane, S.W.; Burbury, K.; Perkins, A.C.; Ross, D.M.